149 related articles for article (PubMed ID: 38578080)
1. Prospective validation of a model-informed precision dosing tool for vancomycin treatment in neonates.
Kalamees R; Soeorg H; Ilmoja M-L; Margus K; Lutsar I; Metsvaht T
Antimicrob Agents Chemother; 2024 May; 68(5):e0159123. PubMed ID: 38578080
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
3. Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.
Kim J; Walker SA; Iaboni DC; Walker SE; Elligsen M; Dunn MS; Allen VG; Simor A
Antimicrob Agents Chemother; 2014 May; 58(5):2830-40. PubMed ID: 24614381
[TBL] [Abstract][Full Text] [Related]
4. The Effectiveness of a Vancomycin Dosing Guideline in the Neonatal Intensive Care Unit for Achieving Goal Therapeutic Trough Concentrations.
Reilly AM; Ding MX; Rower JE; Kiser TH
J Clin Pharmacol; 2019 Jul; 59(7):997-1005. PubMed ID: 30776089
[TBL] [Abstract][Full Text] [Related]
5. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing.
Tang Z; Guan J; Li J; Yu Y; Qian M; Cao J; Shuai W; Jiao Z
Int J Antimicrob Agents; 2021 Mar; 57(3):106300. PubMed ID: 33567334
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of vancomycin in term neonates with perinatal asphyxia treated with therapeutic hypothermia.
van der Veer MAA; de Haan TR; Franken LGW; van Hest RM; Groenendaal F; Dijk PH; de Boode WP; Simons S; Dijkman KP; van Straaten HLM; Rijken M; Cools F; Nuytemans DHGM; van Kaam AH; Bijleveld YA; Mathôt RAA;
Br J Clin Pharmacol; 2024 Jun; 90(6):1418-1427. PubMed ID: 38450797
[TBL] [Abstract][Full Text] [Related]
7. Continuous Learning in Model-Informed Precision Dosing: A Case Study in Pediatric Dosing of Vancomycin.
Hughes JH; Tong DMH; Lucas SS; Faldasz JD; Goswami S; Keizer RJ
Clin Pharmacol Ther; 2021 Jan; 109(1):233-242. PubMed ID: 33068298
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and dose requirements of vancomycin in neonates.
Grimsley C; Thomson AH
Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F221-7. PubMed ID: 10525029
[TBL] [Abstract][Full Text] [Related]
11. Association between vancomycin trough concentration and area under the concentration-time curve in neonates.
Frymoyer A; Hersh AL; El-Komy MH; Gaskari S; Su F; Drover DR; Van Meurs K
Antimicrob Agents Chemother; 2014 Nov; 58(11):6454-61. PubMed ID: 25136027
[TBL] [Abstract][Full Text] [Related]
12. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
[TBL] [Abstract][Full Text] [Related]
13. [Design and validation of a dosing algorithm for vancomycin in premature neonates].
Juan Aguilar M; Ferriols Lisart R; Tosca Segura R; Alós Almiñana M
An Pediatr (Barc); 2008 Feb; 68(2):117-23. PubMed ID: 18341876
[TBL] [Abstract][Full Text] [Related]
14. DosOpt: A Tool for Personalized Bayesian Dose Adjustment of Vancomycin in Neonates.
Tasa T; Metsvaht T; Kalamees R; Vilo J; Lutsar I
Ther Drug Monit; 2017 Dec; 39(6):604-613. PubMed ID: 29084032
[TBL] [Abstract][Full Text] [Related]
15. Actual body weight-based vancomycin dosing in neonates.
Pokorná P; Šíma M; Černá O; Allegaert K; Tibboel D; Slanař O
J Chemother; 2019 Oct; 31(6):307-312. PubMed ID: 30983533
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin pharmacokinetics and dosing in premature neonates.
McDougal A; Ling EW; Levine M
Ther Drug Monit; 1995 Aug; 17(4):319-26. PubMed ID: 7482683
[TBL] [Abstract][Full Text] [Related]
17. Optimization of vancomycin dosing in very low-birth-weight preterm neonates.
Madigan T; Teng CB; Koshaish J; Johnson KR; Graner KK; Banerjee R
Am J Perinatol; 2015 Jan; 32(1):83-6. PubMed ID: 24839147
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin is commonly under-dosed in critically ill children and neonates.
Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
[TBL] [Abstract][Full Text] [Related]
19. Subgroup identification-based model selection to improve the predictive performance of individualized dosing.
Soeorg H; Kalamees R; Lutsar I; Metsvaht T
J Pharmacokinet Pharmacodyn; 2024 Jun; 51(3):253-263. PubMed ID: 38400995
[TBL] [Abstract][Full Text] [Related]
20. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
